SCHEMBL21984089

SCHEMBL21984089

c1ccc(-c2ccc(N(c3ccc4c(c3)sc3ccc(-c5cc(N(c6ccccc6)c6ccccc6)cc(N(c6ccccc6)c6ccccc6)c5)cc34)c3ccc4sc5ccccc5c4c3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LIMK1 P53667 2/20 0.36
PIM3 Q86V86 2/20 0.36
GPR3 P46089 1/20 0.35
CYP1A2 P05177 1/20 0.33
PTPN7 P35236 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN12 Q05209 1/20 0.32
PTPN22 Q9Y2R2 1/20 0.32
F9 P00740 2/20 0.32
TNKS2 Q9H2K2 2/20 0.31
APP P05067 1/20 0.31
TNKS O95271 1/20 0.31
POLB P06746 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18164768 0.99 ALDH1A1 (0.38) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21984093 0.97 MAPT (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL20109528 0.97 MAPT (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21984394 0.97 MAPT (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL18090364 0.96 ALDH1A1 (0.38) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL19660320 0.96 GPR3 (0.38) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL18164742 0.96 GPR3 (0.38) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL18164754 0.96 GPR3 (0.38) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL15614182 0.95 ALDH1A1 (0.37) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL18802549 0.95 MAPT (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200136052-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136052-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF OR10J3, ORAI2, VDAC2 ALDH1A1 2047/4885MAPT 2707/4885HPGD 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.